Tech Company Financing Transactions
Rediscovery Life Sciences Funding Round
On 9/24/2020, Rediscovery Life Sciences raised $4.5 million in Series B investment from Orlando Health, Rex Health Ventures and private investors.
Transaction Overview
Company Name
Announced On
9/24/2020
Transaction Type
Venture Equity
Amount
$4,500,000
Round
Series B
Investors
Orlando Health (Lead Investor) (Sunil Desai)
Rex Health Ventures (Lead Investor) (Anita Watkins)
Proceeds Purpose
The funding will support Phase 2 clinical trial of suramin for treatment of Acute Kidney Injury.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Raleigh, NC 27513
USA
Raleigh, NC 27513
USA
Phone
Website
Email Address
Not Recorded
Overview
Rediscovery Life Sciences is a biopharma company that develops medicines with less risk through drug repurposing. It has various drug repurposing programs queued up, the first of which is RLS-003, a drug to treat Acute Kidney Injury (AKI).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Patrick Donnelly
Chief Executive Officer
Richard Shea
Chief Scientific Officer
Rick Schnellman
Browse more venture capital transactions:
Prev: 9/24/2020: SigmaSense venture capital transaction
Next: 9/24/2020: WhyLabs venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs